Changing from NAFLD to MASLD: Similar prognosis of patients with HCC under atezolizumab/bevacizumab treatment between NAFLD and MASLD

Bibliographic Details
Main Authors:	Hiroyuki Suzuki, Shigeo Shimose, Hideki Iwamoto, Takashi Niizeki, Takumi Kawaguchi
Format:	Article
Language:	English
Published:	Korean Association for the Study of the Liver 2024-04-01
Series:	Clinical and Molecular Hepatology
Subjects:	fatty liver metabolic syndrome immunotherapy hepatocellular carcinoma
Online Access:	http://e-cmh.org/upload/pdf/cmh-2023-0557.pdf

Internet